ORBIT – Sponsored by Thrombogenics

Completed Study | PI: Alex Melamud & T. Mark Johnson

This was a multicenter, prospective, observational Phase 4 study that assessed clinical outcomes and the safety of JETREA®, administered in a real-world setting for the treatment of symptomatic VMA (Vitreomacular Adhesion).

Return to Sub-studies


Loading ...

Ophthalmologist Website Design | Accessibility Policy
Washington DC ORBIT Study | NPDR Treatment in Maryland | Virginia ORBIT Study